Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report for Nevada by County

Ovary (Late Stage^), 2014-2018

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank
County
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
Nevada 6 *** 7.1 (6.5, 7.8) N/A 97 68.5
US (SEER+NPCR) 1 *** 7.7 (7.6, 7.7) N/A 15,434 73.1
Carson City 6 ***
*
*
3 or fewer
*
Churchill County 6 ***
*
*
3 or fewer
*
Clark County 6 *** 6.7 (6.0, 7.5) N/A 65 66.1
Douglas County 6 ***
*
*
3 or fewer
*
Elko County 6 ***
*
*
3 or fewer
*
Esmeralda County 6 ***
*
*
3 or fewer
*
Eureka County 6 ***
*
*
3 or fewer
*
Humboldt County 6 ***
*
*
3 or fewer
*
Lander County 6 ***
*
*
3 or fewer
*
Lincoln County 6 ***
*
*
3 or fewer
*
Lyon County 6 ***
*
*
3 or fewer
*
Mineral County 6 ***
*
*
3 or fewer
*
Nye County 6 ***
*
*
3 or fewer
*
Pershing County 6 ***
*
*
3 or fewer
*
Storey County 6 ***
*
*
3 or fewer
*
Washoe County 6 *** 8.3 (6.6, 10.2) N/A 18 78.3
White Pine County 6 ***
*
*
3 or fewer
*
Notes:
Created by statecancerprofiles.cancer.gov on 10/22/2021 12:15 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Carson City, Churchill, Clark, Douglas, Elko, Esmeralda, Eureka, Humboldt, Lander, Lincoln, Lyon, Mineral, Nye, Pershing, Storey, Washoe, White Pine

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.

Return to Top